Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immunofluorescence Microscopy01:12

Immunofluorescence Microscopy

A fluorescence microscope uses fluorescent chromophores called fluorochromes, which can absorb energy from a light source and then emit this energy as visible light. Fluorochromes include naturally fluorescent substances (such as chlorophylls) and fluorescent stains that are added to the specimen to create contrast. Dyes such as Texas red and FITC are examples of fluorochromes. Other examples include the nucleic acid dyes 4’,6’-diamidino-2-phenylindole (DAPI), and acridine orange.
The...
Immunocytochemistry and Immunohistochemistry01:22

Immunocytochemistry and Immunohistochemistry

Immunocytochemistry (ICC) and immunohistochemistry (IHC) are techniques that use antibodies to check for specific proteins or antigens in a sample. The technique was first published by Albert Coons in 1941 to detect the presence of pneumococcal antigen in tissue sections from mice infected with Pneumococcus. Immunocytochemistry helps localization of proteins or antigens in individual cells like blood cells, stem cells, etc., while immunohistochemistry does the same for tissue samples.
These...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A rare case of orbital heavy chain amyloidosis.

Orbit (Amsterdam, Netherlands)·2026
Same author

Exploring the significance of EGFR, MMP-2, MMP-9, HIF-1α, and CAIX as molecular biomarkers in ocular surface squamous neoplasia.

The Indian journal of medical research·2026
Same author

Clinico-demographic profile and management outcomes of periocular and subconjunctival dirofilariasis in South India.

Indian journal of ophthalmology·2026
Same author

CD 34 negative orbital solitary fibrous tumor: report of a rare case with prognostic implications.

Orbit (Amsterdam, Netherlands)·2026
Same author

Orbital and Adnexal IgG4-related disease: An insight into the clinical profile and management outcomes.

Indian journal of ophthalmology·2025
Same author

A rare case of precursor B-cell lymphoblastic lymphoma of the orbit in a child.

Oman journal of ophthalmology·2025

Related Experiment Video

Updated: Jul 15, 2026

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography
05:46

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography

Published on: December 2, 2022

Cripto-1 expression in uveal melanoma: an immunohistochemical study.

Kandalam Mallikarjuna1, Pushparaj Vaijayanthi, Subramanian Krishnakumar

  • 1Department of Ocular Pathology, Vision Research Foundation, Sankara Nethralaya, 18 College Road, Nungambakkam, Chennai 600 006, Tamil Nadu, India.

Experimental Eye Research
|April 7, 2007
PubMed
Summary

Cripto-1 is overexpressed in uveal melanoma, a cancer of the eye, but not in normal ocular tissues. This finding suggests Cripto-1 could be a potential therapeutic target for uveal melanoma treatment.

More Related Videos

DNA-barcode-based Multiplex Immunofluorescence Imaging to Analyze FFPE Specimens from Genetically Reprogrammed Murine Melanoma
09:58

DNA-barcode-based Multiplex Immunofluorescence Imaging to Analyze FFPE Specimens from Genetically Reprogrammed Murine Melanoma

Published on: June 6, 2025

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

Related Experiment Videos

Last Updated: Jul 15, 2026

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography
05:46

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography

Published on: December 2, 2022

DNA-barcode-based Multiplex Immunofluorescence Imaging to Analyze FFPE Specimens from Genetically Reprogrammed Murine Melanoma
09:58

DNA-barcode-based Multiplex Immunofluorescence Imaging to Analyze FFPE Specimens from Genetically Reprogrammed Murine Melanoma

Published on: June 6, 2025

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

Area of Science:

  • Oncology
  • Molecular Biology
  • Ophthalmology

Background:

  • Cripto-1, a member of the epidermal growth factor-Cripto-FRL1-Cryptic (EGF-CFC) family, is crucial for embryonic development and implicated in various cancers.
  • Overexpression of Cripto-1 is common in many cancers, while its expression is minimal in normal cells, making it a potential target for cancer therapies.
  • The expression of Cripto-1 in human uveal melanoma, a rare eye cancer, was previously uncharacterized.

Purpose of the Study:

  • To investigate the expression and localization of Cripto-1 in human uveal melanoma.
  • To determine if Cripto-1 expression correlates with tumor aggressiveness.
  • To evaluate Cripto-1 as a potential therapeutic target for uveal melanoma.

Main Methods:

  • Immunohistochemistry was employed to assess Cripto-1 reactivity in 36 archival uveal melanoma samples.
  • Uveal melanoma tumors were categorized into non-invasive and aggressive groups based on tumor extension and metastasis.
  • Cripto-1 immunolocalization was studied in four uveal melanoma cell lines and two primary uveal melanocyte cultures.

Main Results:

  • Cripto-1 was expressed in both non-invasive and aggressive human uveal melanomas.
  • Cripto-1 reactivity showed a correlation with tumor aggressiveness and cell type.
  • All four tested uveal melanoma cell lines expressed Cripto-1, whereas primary uveal melanocytes and normal retinal tissue did not.

Conclusions:

  • Cripto-1 is expressed in human uveal melanoma, distinguishing it from non-neoplastic ocular tissues.
  • The expression of Cripto-1 in uveal melanoma suggests its potential utility as a target for novel therapeutic strategies.
  • Targeting Cripto-1 may offer a promising avenue for the treatment of uveal melanoma.